The Bull of Wall Street15 Syys 2025

#41 - Dr. Matthew Schwartz, MD and Dr. Thomas Dayspring, MD, FACP, FNLA on Cancer Innovation, Cardiovascular Disease Prevention, and What Everyone Needs to Know (recorded 09/15/25)

Health is wealth, and as advisors the impact we make extends beyond portfolios. In this two-part episode, Jimmy Lee first sits down with his good friend Dr. Matthew Schwartz, radiation oncologist and UNLV faculty member, to explore how proteomics is changing cancer treatment. Then Dr. Thomas Dayspring, one of the world’s foremost educators on lipids and mentor to Dr. Peter Attia, explains why cardiovascular disease remains the number one preventable cause of death, plus the simple blood tests and treatments that can save lives.
Disclaimer: This episode is for informational purposes only and does not constitute medical advice. Please consult your physician for personal medical guidance.

What you’ll learn:

How proteomics differs from genomics and why it could be a game changer for cancer care
Why many oncologists are not yet using this testing and what patients and families should know
The role of precision oncology in identifying the right treatment at the right time
Why cardiovascular disease is still the leading killer, and how ApoB and Lp(a) testing can change outcomes
Treatment options that go far beyond good vs. bad cholesterol, and what longevity-focused medicine recommends
Practical steps advisors and their clients can take to advocate for their health

Chapters
00:00 – Welcome and episode purpose
02:18 – Dr. Matthew Schwartz on proteomics vs. genomics
07:06 – How Ignite testing works and why it matters
11:07 – Effectiveness, adoption, and access for patients
16:31 – Awareness, advocacy, and making cancer a chronic disease
21:23 – Dr. Thomas Dayspring on cardiovascular disease prevention
28:36 – ApoB and why particle number drives risk
40:12 – Lipoprotein(a), genetics, and early testing
52:08 – Treatment options: lifestyle, statins, PCSK9s
58:40 – Lowering ApoB, plaque, and longevity goals
01:19:21 – Target numbers and why very low is safe
01:26:23 – New therapies for Lp(a) and what’s ahead
01:33:20 – Diet, imaging, and practical takeaways
01:37:56 – Education gap and being your own advocate
01:42:39 – Closing thoughts and advisor role
Guests:
Dr. Matthew Schwartz, MD, Radiation Oncologist, Comprehensive Cancer Centers of Nevada
Dr. Thomas Dayspring, MD, FACP, FNLA, Educator on Lipids, Early Medical
Host: Jimmy Lee, CEO, The Wealth Consulting Group
Follow us
LinkedIn: https://www.linkedin.com/company/the-wealth-consulting-group/
X (Twitter): @WealthCG
YouTube: @thewealthconsultinggroup
Making Life Better at The Wealth Consulting Group
If you are ready to see how WCG helps advisors grow, subscribe for insights, updates, and resources built to make your practice and your life better.
Subscribe at bit.ly/wealthcg

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(84)

Ep. 85: Factor Investing, Avoiding Value Traps, and AI in Asset Management, with Avantis CIO Eduardo Repetto (09/16/26))

In episode 85, hosts Jim Worden and Paisley Nardini are joined by Eduardo Repetto, Chief Investment Officer of Avantis Investors, for a conversation on factor-based investing and portfolio constructio...

16 Syys 1h 5min

Ep. 84: Sudden Wealth Syndrome, Raising Money-Smart Kids, and NIL Education for Athletes, with Tom Henske (recorded 09/03/26)

In episode 84, host Jimmy Lee is joined by Tom Henske, CFP and founder of The Affluent Insurance Advisor, for a wide-ranging conversation on sudden wealth, financial literacy, and building a referral-...

3 Syys 56min

Ep. 83: Building Enterprise Value, Multi-Generational Growth, and the Case for Outsourcing, with First Trust VP Jackie Wilke (recorded 08/27/26)

In episode 83, host Jimmy Lee is joined by Jackie Wilke, Vice President and Advisor Consultant with First Trust's Advisor Consulting Group, for a wide-ranging conversation on practice management for f...

27 Elo 1h 5min

Ep. 82: Factor Rotation, AI Chip Competition, and What's Driving the Market Higher (recorded 8/19/26)

In episode 82, Talley Leger and Jim Worden of The Wealth Consulting Group host a two-person deep dive (no outside guest this week) on investment factors, AI-driven competition, and market valuation. T...

19 Elo 44min

Ep. 81: Fed Guidance, the K-Shaped Economy & the AI Investment Boom, with Fundstrat Economics Strategist Hardika Singh (recorded 08/12/26)

In episode 81, hosts Talley Leger and Jim Worden of The Wealth Consulting Group welcome Hardika Singh, economics strategist at Fundstrat and a former Wall Street Journal and Bloomberg reporter, for a ...

12 Elo 50min

#80 - Jonathan Golub, Chief Equity Strategist at Seaport Research Partners: AI, Earnings, Valuations, and the Changing Market Regime (recorded 08/05/26)

In this episode of The Bull of Wall Street, Talley Leger and Jim Worden welcome Jonathan Golub, Chief Equity Strategist at Seaport Research Partners, for a discussion on artificial intelligence, corpo...

5 Elo 1h 5min

#79 - John Diehl & Dr. Joe Coughlin (recorded 07/30)

Dr. Joseph Coughlin and John Diehl: Longevity, Aging, and the Future of Financial AdviceSummaryIn this episode of The Bull of Wall Street, Jimmy Lee sits down with Dr. Joseph Coughlin, Founder and Dir...

31 Heinä 1h 4min

#78 - Dave Keller, President and Chief Strategist at Sierra Alpha Research: Technical Analysis, Investor Behavior, and Navigating Market Rotations (recorded 07/29/26)

In this episode of The Bull of Wall Street, Jim Worden and Talley Leger sit down with Dave Keller, President and Chief Strategist at Sierra Alpha Research, to explore how technical analysis, behaviora...

30 Heinä 1h